Evidence map›Paper›PMID 9223294›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc.

R Bronson, C Dawe, J Carroll, T Benjamin

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.Microbiology and molecular biology reviews : MMBR · 2009
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. A tumor host range selection procedure identifies p150(sal2) as a target of polyoma virus large T antigen.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  13. Natural biology of polyomavirus middle T antigen.Microbiology and molecular biology reviews : MMBR · 2001
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

R BronsonTufts University School of Veterinary Medicine, Boston, MA, 02118, USA.
C Dawe
J Carroll
T Benjamin
Harvard University · USTufts University · US

Funding

PHS HHS R35-44343
6 · The paper itself

Abstract

Transformation of cells in culture by polyoma virus requires integration of signals downstream of middle T-Shc and middle T-phosphatidylinositol 3-kinase interactions, but the same is not true for induction of tumors in the mouse. Thus, a middle T mutant defective in transformation and blocked in binding Shc is able to induce a broad spectrum of tumors after inoculation into newborn mice. The "tumor profile" induced by the mutant shows enhancement of tumors at some sites and reductions at others but otherwise resembles that induced by the wild-type virus. A nontransforming double-mutant blocked in binding phosphatidylinositol 3-kinase as well as Shc is severely affected but still induces some tumors. These results show that pathways that must cooperate to induce full transformation of cells in vitro can act independently and are to a large extent redundant in tumor induction.

Indexed as

3T3 CellsAnimalsAnimals, NewbornCell Transformation, NeoplasticCell Transformation, ViralMaleMiceMutagenesis, Site-DirectedPolyomavirusProteinsSignal TransductionVirus ReplicationProteins

Identifiers

PMID9223294
PMCPMC21536
OpenAlexW2031294112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.